CD4 and myeloid sarcoma: This is supported by the IMSGC’s 2019 study, where SNPs within the rs6742 susceptibility locus were all associated with reduced SLC2A4RG expression in CD4 + T-cells in an MS cohort [6] (Additional file 1: Table S11).